These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 31578209)

  • 1. An Accurate In Vitro Prediction of Human VD
    Berellini G; Lombardo F
    Drug Metab Dispos; 2019 Dec; 47(12):1380-1387. PubMed ID: 31578209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applicability of the Øie-Tozer model to predict three types of distribution volume (Vd) in humans: Vd in central compartment, Vd at steady state, and Vd at beta phase.
    Yahata M; Ishii Y; Nakagawa T; Watanabe T; Miyawaki I
    Biopharm Drug Dispos; 2020 Apr; 41(4-5):151-165. PubMed ID: 32187715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 4: prediction of plasma concentration-time profiles in human from in vivo preclinical data by using the Wajima approach.
    Vuppugalla R; Marathe P; He H; Jones RD; Yates JW; Jones HM; Gibson CR; Chien JY; Ring BJ; Adkison KK; Ku MS; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Poulin P
    J Pharm Sci; 2011 Oct; 100(10):4111-26. PubMed ID: 21480234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative Performance of Volume of Distribution Prediction Methods for Lipophilic Drugs with Uncertainty in LogP Value.
    Coutinho AL; Cristofoletti R; Wu F; Al Shoyaib A; Dressman J; Polli JE
    Pharm Res; 2024 Jun; 41(6):1121-1138. PubMed ID: 38720034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
    Lombardo F; Obach RS; Shalaeva MY; Gao F
    J Med Chem; 2002 Jun; 45(13):2867-76. PubMed ID: 12061889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 2: comparative assessment of prediction methods of human volume of distribution.
    Jones RD; Jones HM; Rowland M; Gibson CR; Yates JW; Chien JY; Ring BJ; Adkison KK; Ku MS; He H; Vuppugalla R; Marathe P; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Poulin P
    J Pharm Sci; 2011 Oct; 100(10):4074-89. PubMed ID: 21452299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Silico Prediction of Volume of Distribution in Humans. Extensive Data Set and the Exploration of Linear and Nonlinear Methods Coupled with Molecular Interaction Fields Descriptors.
    Lombardo F; Jing Y
    J Chem Inf Model; 2016 Oct; 56(10):2042-2052. PubMed ID: 27602694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug Distribution to Human Tissues: Prediction and Examination of the Basic Assumption in In Vivo Pharmacokinetics-Pharmacodynamics (PK/PD) Research.
    Poulin P
    J Pharm Sci; 2015 Jun; 104(6):2110-2118. PubMed ID: 25808270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 1: goals, properties of the PhRMA dataset, and comparison with literature datasets.
    Poulin P; Jones HM; Jones RD; Yates JW; Gibson CR; Chien JY; Ring BJ; Adkison KK; He H; Vuppugalla R; Marathe P; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Ku MS
    J Pharm Sci; 2011 Oct; 100(10):4050-73. PubMed ID: 21523782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
    Lombardo F; Obach RS; Shalaeva MY; Gao F
    J Med Chem; 2004 Feb; 47(5):1242-50. PubMed ID: 14971904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Silico Models of Human PK Parameters. Prediction of Volume of Distribution Using an Extensive Data Set and a Reduced Number of Parameters.
    Lombardo F; Bentzien J; Berellini G; Muegge I
    J Pharm Sci; 2021 Jan; 110(1):500-509. PubMed ID: 32891631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing Mechanistic and Preclinical Predictions of Volume of Distribution on a Large Set of Drugs.
    Chan R; De Bruyn T; Wright M; Broccatelli F
    Pharm Res; 2018 Mar; 35(4):87. PubMed ID: 29520503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
    Sui X; Sun J; Li H; Wang Y; Liu J; Liu X; Zhang W; Chen L; He Z
    Eur J Med Chem; 2009 Nov; 44(11):4455-60. PubMed ID: 19586686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Øie-Tozer model of drug distribution and its suitability for drugs with different pharmacokinetic behavior.
    Stepensky D
    Expert Opin Drug Metab Toxicol; 2011 Oct; 7(10):1233-43. PubMed ID: 21919805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of volume of distribution in humans: analysis of eight methods and their application in drug discovery.
    Petersson C; Papasouliotis O; Lecomte M; Badolo L; Dolgos H
    Xenobiotica; 2020 Mar; 50(3):270-279. PubMed ID: 31215316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting Volume of Distribution in Humans: Performance of In Silico Methods for a Large Set of Structurally Diverse Clinical Compounds.
    Murad N; Pasikanti KK; Madej BD; Minnich A; McComas JM; Crouch S; Polli JW; Weber AD
    Drug Metab Dispos; 2021 Feb; 49(2):169-178. PubMed ID: 33239335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical pharmacokinetics of MI-219, a novel human double minute 2 (HDM2) inhibitor and prediction of human pharmacokinetics.
    Zou P; Zheng N; Yu Y; Yu S; Sun W; McEachem D; Yang Y; Yu LX; Wang S; Sun D
    J Pharm Pharm Sci; 2012; 15(2):265-80. PubMed ID: 22579006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A New Version of the Tissue Composition-Based Model for Improving the Mechanism-Based Prediction of Volume of Distribution at Steady-State for Neutral Drugs.
    Poulin P; Nicolas JM; Bouzom F
    J Pharm Sci; 2024 Jan; 113(1):118-130. PubMed ID: 37634869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of the Øie-Tozer model in understanding mechanisms and determinants of drug distribution.
    Waters NJ; Lombardo F
    Drug Metab Dispos; 2010 Jul; 38(7):1159-65. PubMed ID: 20375179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a novel method for predicting human volume of distribution at steady-state of basic drugs and comparative assessment with existing methods.
    Poulin P; Theil FP
    J Pharm Sci; 2009 Dec; 98(12):4941-61. PubMed ID: 19455625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.